ERLIN2 and prostate adenocarcinoma: Subsequently, ERLIN2 was verified to be lowly expressed in PCa and associated with a good prognosis in TCGA-PRAD, including OS and PFI (Fig. 2B), whereas CDK5RAP3 was highly expressed in PCa and associated with a bad prognosis (Fig. 2C).